PRENW
Prenetics Holding Company LimitedNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-11.04
Beta
0.25
52W High
$0.04
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-42.00%
Forward P/E
—
PEG Ratio
—
About Prenetics Holding Company Limited
Prenetics Holding Company Limited is a pioneering healthcare technology firm dedicated to enhancing health outcomes through innovative genetic testing and digital health solutions. Offering a comprehensive array of genetic screening and diagnostics services, the company utilizes advanced technologies and data analytics to facilitate personalized medicine and provide actionable health insights. As the demand for precision health solutions continues to grow, Prenetics stands strategically positioned to leverage emerging opportunities in the evolving, data-driven healthcare landscape, presenting an appealing prospect for institutional investors focused on growth within the health tech sector.
Fundamentals
| Revenue (TTM) | $120.07M |
| Gross Profit (TTM) | $66.47M |
| EBITDA | $-40.82M |
| Operating Margin | -24.70% |
| Return on Equity | -40.80% |
| Return on Assets | -13.50% |
| Revenue/Share (TTM) | $7.98 |
| Book Value | $9.76 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 107.70% |
| Shares Outstanding | 0 |
| Float | $12.64M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
100.00%
HV 30-Day
93.10%
HV 60-Day
129.59%
HV Rank
—
Volatility is currently contracting
Data last updated: 7/9/2026